Results
1
Stocks which the market has priced substantially different to their cash flows, which could imply risk.
1 companies
Arterra Bioscience
Market Cap: €20.2m
A research-based biotech company, engages in the research and development of various ingredients and natural solutions.
ARBS
€3.03
7D
-1.3%
1Y
10.6%